Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record for a Phase 2 trial of cabozantinib in Japanese participants with advanced hepatocellular carcinoma is displayed, including its design, eligibility criteria, outcome measures, locations, and study documents.SummaryDifference63%

- Check19 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedAn NIH announcement about changes to NIH websites appears above the 403 error message.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record content with a generic error view. Previously visible content such as PDFs, SAP, protocol, and location details are no longer accessible on the page.SummaryDifference19%

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.